How to Pressure-Test Your Sales Pipeline Before Q4

Written by Sergio Armani, Founder of ACG-Clinical

Let’s be real.

Most clinical research vendors are heading into Q4 with a “pipeline” that’s more of a wish list than a sales plan.

Too many deals are stuck in limbo. Too many reps are chasing ghosts. And too many leaders are shocked when Q4 rolls around and revenue doesn’t land.

That’s not a forecasting problem — it’s a discipline problem.

If you’re serious about ending the year strong, now’s the time to pressure-test your pipeline — before your team spends the next 90 days chasing deals that were never real to begin with.

🔒 The rest of this article is available inside Bold Thinking Insider — your free membership hub for sales strategy, industry insights, and Bold Insights Weekly.

👉 Join Bold Thinking Insider (free until Dec 31, 2025) to keep reading.

Disclaimer
The information in this publication is for general informational purposes only and should not be construed as legal, financial, or regulatory advice. Armani Consulting Group, LLC, doing business as ACG-Clinical, disclaims any liability for errors, omissions, or actions taken in reliance on this content. Please consult qualified professionals for advice specific to your situation.